Authors: |
Burstein, H. J.; Piccart-Gebhart, M. J.; Perez, E. A.; Hortobagyi, G. N.; Wolmark, N.; Albain, K. S.; Norton, L; Winer, E. P.; Hudis, C. A. |
Article Title: |
Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines? |
Journal Title: |
Journal of Clinical Oncology
|
Volume: |
30 |
Issue: |
18 |
ISSN: |
0732-183X |
Publisher: |
Unknown
|
Journal Place: |
United States |
Date Published: |
2012 |
Start Page: |
2179 |
End Page: |
2182 |
Language: |
eng |
DOI/URL: |
|
Notes: |
LR: 20130508; JID: 8309333; 0 (Anthracyclines); 0 (Antibodies, Monoclonal, Humanized); EC 2.7.10.1 (Receptor, erbB-2); P188ANX8CK (trastuzumab); CIN: J Clin Oncol. 2012 Dec 10;30(35):4445-6; author reply 4446. PMID: 23071231; 2012/05/21 [aheadofprint]; ppublish |